<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Polikanov YS</submitter><funding>Howard Hughes Medical Institute</funding><funding>National Center of Neurology and Psychiatry</funding><funding>Ministry of Education, Culture, Sports, Science and Technology</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><pagination>541-50</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4334386</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>56(4)</volume><pubmed_abstract>Negamycin (NEG) is a ribosome-targeting antibiotic that exhibits clinically promising activity. Its binding site and mode of action have remained unknown. We solved the structure of the Thermus thermophilus ribosome bound to mRNA and three tRNAs, in complex with NEG. The drug binds to both small and large ribosomal subunits at nine independent sites. Resistance mutations in the 16S rRNA unequivocally identified the binding site in the vicinity of the conserved helix 34 (h34) in the small subunit as the primary site of antibiotic action in the bacterial and, possibly, eukaryotic ribosome. At this site, NEG contacts 16S rRNA as well as the anticodon loop of the A-site tRNA. Although the NEG site of action overlaps with that of tetracycline (TET), the two antibiotics exhibit different activit</pubmed_abstract><journal>Molecular cell</journal><pubmed_title>Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.</pubmed_title><pmcid>PMC4334386</pmcid><funding_grant_id>25650106</funding_grant_id><funding_grant_id>P01 GM022778</funding_grant_id><funding_grant_id>GM022778</funding_grant_id><funding_grant_id>R01 GM106386</funding_grant_id><funding_grant_id>GM106386</funding_grant_id><funding_grant_id>23-5</funding_grant_id><pubmed_authors>Szal T</pubmed_authors><pubmed_authors>Shiozuka M</pubmed_authors><pubmed_authors>Jiang F</pubmed_authors><pubmed_authors>Vazquez-Laslop N</pubmed_authors><pubmed_authors>Matsuda R</pubmed_authors><pubmed_authors>Steitz TA</pubmed_authors><pubmed_authors>Mankin AS</pubmed_authors><pubmed_authors>Polikanov YS</pubmed_authors><pubmed_authors>Gupta P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Negamycin interferes with decoding and translocation by simultaneous interaction with rRNA and tRNA.</name><description>Negamycin (NEG) is a ribosome-targeting antibiotic that exhibits clinically promising activity. Its binding site and mode of action have remained unknown. We solved the structure of the Thermus thermophilus ribosome bound to mRNA and three tRNAs, in complex with NEG. The drug binds to both small and large ribosomal subunits at nine independent sites. Resistance mutations in the 16S rRNA unequivocally identified the binding site in the vicinity of the conserved helix 34 (h34) in the small subunit as the primary site of antibiotic action in the bacterial and, possibly, eukaryotic ribosome. At this site, NEG contacts 16S rRNA as well as the anticodon loop of the A-site tRNA. Although the NEG site of action overlaps with that of tetracycline (TET), the two antibiotics exhibit different activit</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Nov</publication><modification>2025-06-28T03:05:18.036Z</modification><creation>2025-06-28T03:05:18.036Z</creation></dates><accession>S-EPMC4334386</accession><cross_references><pubmed>25306922</pubmed><doi>10.1016/j.molcel.2014.09.021</doi></cross_references></HashMap>